STOCK TITAN

Korsana Biosciences officer proposes 10,001-share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Korsana Biosciences, Inc. (KRSA) officer and director Regina Margaret Graul filed a notice listing 10,001 common shares for sale, with an aggregate market value of $374,315.43. The notice gives November 20, 2026, as the approximate sale date and names Morgan Stanley Smith Barney LLC as broker. The shares were acquired upon vesting of restricted stock during November 7, 2019, through July 16, 2026.

Common shares listed for sale 10,001 shares Form 144 notice
Aggregate market value $374,315.43 Shares listed for sale
Shares outstanding 45,541,358 shares Count shown in the securities information
Restricted Stock financial
"acquired upon the vesting of restricted stock"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KRSA shares is Regina Margaret Graul proposing to sell?

The notice lists 10,001 common shares for sale, with an aggregate market value of $374,315.43.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading